Biotech companies Oncology Venture and Medical Prognosis Institute are planning a merger that will take the companies from the Swedish stock exchanges for growth companies to Stockholm's main market. "Investors and potential partners have expressed their desirefor a one-stop-shop and this is what we comply with," says the CEO in both companies.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.